Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension - Wikidata - awgldk - TriplyDB

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension

http://www.wikidata.org/entity/Q28582609

about

Hypoxia upregulates PGI-synthase and increases PGI₂ release in human vascular cells exposed to inflammatory stimuli Genomic approaches to research in pulmonary hypertension An efficient method to successively introduce transgenes into a given genomic locus in the mouse Inhaled therapy for the management of perioperative pulmonary hypertension Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs Genetically manipulated mouse models of lung disease: potential and pitfalls A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Attenuation of monocrotaline-induced pulmonary hypertension by luminal adeno-associated virus serotype 9 gene transfer of prostacyclin synthase Internalization and sequestration of the human prostacyclin receptor.Pulmonary oxidative stress is increased in cyclooxygenase-2 knockdown mice with mild pulmonary hypertension induced by monocrotaline The lung HETEs (and EETs) up.Sex hormones and vascular protection in pulmonary arterial hypertension.Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics New treatments for pulmonary arterial hypertension.Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma.Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.Pulmonary hypertension in the young.Paracrine effects of bone marrow-derived endothelial progenitor cells: cyclooxygenase-2/prostacyclin pathway in pulmonary arterial hypertension.S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy Role of prostacyclin in pulmonary hypertension.EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling.Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke.The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.Cyclooxygenase-1 overexpression decreases Basal airway responsiveness but not allergic inflammation.Vascular dysfunction in a murine model of severe hemolysis.Differences between basal lung levels of select eicosanoids in rat and mouse Pathophysiology of pulmonary arterial hypertension.Future perspectives for the treatment of pulmonary arterial hypertension.Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells.Role of chemokine C-C motif ligand-1 in acute and chronic pulmonary inflammations PGI synthase overexpression protects against bleomycin-induced mortality and is associated with increased Nqo 1 expression Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.Inhaled iloprost for the control of pulmonary hypertension.Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.Selective inhibition of prostacyclin synthase activity by rofecoxib.Pulmonary perfusion imaging in the rodent lung using dynamic contrast-enhanced MRI.

P2860

48699abc21d9a845eb7da40e496d5453f6f96677 834ba90cfae5e6651f43428971e20bbf6e1acc3c

P248

Q24339277-AE2454D1-37D0-4A7E-A568-C49100CD3052 Q24792044-335AC4FA-87B1-4EE4-8038-17C6E06A3891 Q24800214-6051A079-0F08-4235-BD58-DA7A166FFEC0 Q27026522-E2F240E5-B8F3-46CD-A567-1E9814774D23 Q28218337-0426F379-C302-4065-896F-663FAA2B58F3 Q28388821-222BE338-A730-4D20-8263-F0D9EEADF04C Q30544892-3A83F190-4722-4C48-AD31-537926CF81AC Q33782838-5CA12316-7366-47AB-906E-E7C598CADBC2 Q33908973-1EBDF5DA-07A3-411D-9231-C0EF8B1449EE Q33995716-B4F7FA8C-3EB9-4C07-997D-86173E728FBD Q34109234-8FCCD1B9-4B92-4288-B5A7-39361793D75C Q34297770-BC3C749E-DB10-42D2-A7D0-DD3EF72B02C4 Q34344390-27B80D40-6E8A-4273-BD1F-5CE66396A9F5 Q34625826-AC318366-CDE3-4AF3-A653-D72BE666E0D7 Q34720201-3B5A86FE-6479-4985-B023-C660726540BF Q34730034-0CB81F84-21DC-4B19-9EA6-92DC2696E4E7 Q34994448-9C694C74-33FD-4681-8B2A-DF82055B39CE Q34998559-F8AB89F8-7DCA-4586-AC26-9702B24891FB Q35048253-A081AA44-0E21-4B8D-A7D9-4A86CECA30FF Q35083293-3E3ED220-7511-4B85-9AC4-A80A6666EA21 Q35165100-0B5AE9BF-81E3-482E-AA66-058506C2C31F Q35183959-66BB481B-7769-44C7-BE4B-4833EDA61377 Q35537798-CBD431BE-19BF-4056-BB3C-7AABBA14ACF6 Q35855195-97E2F2AD-69EF-44ED-B260-964AEFC3112A Q35925357-21D91DCD-4304-4DBF-99A2-1DB7EF5A2556 Q35994471-EF583A0D-6B8F-4B11-B097-FAB49543A8C9 Q36105461-2FA6D417-9256-4C90-8F6A-663FE4532ED1 Q36420377-932B8940-A873-43D7-8569-E38991500487 Q36742507-C4D2065F-DF77-4831-8B6E-F3699DFD7FEC Q36810849-CB458E31-CE2F-41D1-A7E9-400BB9D87852 Q36834621-6711908C-054F-41BF-BF35-1425ADD74E4D Q36943648-75D3B46A-A7D6-4163-84D6-3E4BAD94BE5F Q36982666-9E455ED3-911E-4ED8-82AB-0130D71EB2CC Q37146836-CDD829A0-5874-42A4-9725-9C2E815DFA97 Q37174722-41643C87-240E-4AA9-AB33-434A4CD4B2CD Q37187131-51233E7D-018C-43F2-9C2B-A93719BFCF4D Q37202163-20FC75EE-124E-4018-A1EC-06710EE720DE Q37290958-2C9946CA-E4C5-4438-9BF5-7E06827F0C2F Q37294580-2AAC2513-55AF-4B62-9458-AA2128381DDD Q37334704-C4FC7DEC-B386-4040-9391-5505615FD2BD

P2860

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension

http://www.wikidata.org/entity/Q28582609

description

1999 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունիսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 1999

@ast

im Juni 1999 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 1999/06/01)

@sk

vědecký článek publikovaný v roce 1999

@cs

wetenschappelijk artikel (gepubliceerd op 1999/06/01)

@nl

наукова стаття, опублікована в червні 1999

@uk

مقالة علمية (نشرت في يونيو 1999)

@ar

name

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@ast

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@en

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@nl

type

label

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@ast

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@en

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@nl

prefLabel

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@ast

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@en

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@nl

P1433

Q28582609-2A4F4EF7-9475-4583-B359-3F524350A84A

P1476

Q28582609-4C4122CD-D7CD-4AB1-BD6B-789A64391C5E

P2093

Q28582609-6F0A118B-6E38-4F4F-B57C-4A844F51860B

Q28582609-74A5F48E-DDCB-43FE-97A2-BC885E0B1E15

Q28582609-8BB3D50A-AFEE-4EA4-B044-DD33DFA9371D

Q28582609-8CA4BF82-98CE-4BD2-BF64-7E0B6EDF5864

Q28582609-9AC78325-1276-48FF-A0B0-48409C1B5D93

Q28582609-A90CCED2-FA76-4D3E-AE66-0F122400FDA3

Q28582609-BECB7D1A-2B44-4D33-BAF0-1E94E35ACD28

Q28582609-E3291E68-F998-46FD-8AC5-3FDC2139E016

Q28582609-F2D1AA21-E2C0-460E-B639-CCA3DC469DCA

P2860

Q28582609-061D24E4-2B0C-403B-8D9F-86CCD964189C

Q28582609-0DF1B49F-9FEF-4BD7-B34A-DEA790AE7806

Q28582609-13B70740-503D-4A53-B3A5-BD7B4D76450F

Q28582609-2479F1B0-FD70-432D-973C-FDEDFAC86611

Q28582609-32D7A861-177B-40AF-8070-BAA9194349AE

Q28582609-4398F918-4158-4B70-ACC7-4A2069D24461

Q28582609-4B49D990-6321-4AB3-95A4-499C12486BA8

Q28582609-60304C4B-5CD0-4960-8E53-24183709B133

Q28582609-678C33B6-C539-48B2-B02A-E6FBEC743E71

Q28582609-76815C68-DD8A-41DE-BA83-5DCE980A7667

P304

Q28582609-DB1D82BD-2E64-48E1-A5EF-8A0D266BA646

P31

Q28582609-B44CCF0E-E093-4A22-8825-3475A48F77BD

P3181

Q28582609-33357A65-C414-47EB-8CD3-CFADC996ACA6

P356

Q28582609-993FA9A9-665A-45C6-A153-E5B82E6AC8B4

P407

Q28582609-39A2BC8A-93A2-4563-92F2-7CEDE29C0394

P433

Q28582609-9E1804D6-2275-4213-8665-70F466A6EF9D

P478

Q28582609-F3F0A92D-EA43-4711-B85D-CB1F508AA8E6

P577

Q28582609-8EDCF24B-D659-4087-823D-16E3C2E822DD

P5875

Q28582609-CEE2CB6A-8BF3-4BAE-8F27-D732DCEA46BB

P698

Q28582609-0C66C7B3-E373-4883-8A6C-7F30AA393F1E

P921

Q28582609-255BE8A1-58BA-44D1-B8F1-1391DE601F51

Q28582609-3914383E-0F9E-4E1F-90E7-6B176C9A2BE5

Q28582609-6DA8D248-DC1F-4C79-B749-DC54CDB11008

P932

Q28582609-EBF344E1-DEB0-49C2-AF67-DF1752F02C77

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Pulmonary prostacyclin synthas ...... hypoxic pulmonary hypertension

@en

P2093

B. Gao

http://www.w3.org/2001/XMLSchema#string

D. C. Shepherd

http://www.w3.org/2001/XMLSchema#string

J. Y. Westcott

http://www.w3.org/2001/XMLSchema#string

K. A. Fagan

http://www.w3.org/2001/XMLSchema#string

L. A. Alger

http://www.w3.org/2001/XMLSchema#string

M. D. Moore

http://www.w3.org/2001/XMLSchema#string

M. W. Geraci

http://www.w3.org/2001/XMLSchema#string

N. F. Voelkel

http://www.w3.org/2001/XMLSchema#string

R. M. Tuder

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of human prostacyclin synthase

Two SP-C genes encoding human pulmonary surfactant proteolipid

Pathology and pathophysiology of primary pulmonary hypertension.

Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice.

Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery. Alterations after prolonged hypoxia in the rat.

Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.

Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells.

Molecular cloning and characterization of bovine prostacyclin synthase.

Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.

P304

1509–1515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4336236

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI5911

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12938535

http://www.w3.org/2001/XMLSchema#string

P698

10359560

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

408370

http://www.w3.org/2001/XMLSchema#string